TrialThe Journal of clinical endocrinology and metabolism2015

Medical Castration Using the Investigational Oral GnRH Antagonist TAK-385 (Relugolix): Phase 1 Study in Healthy Males.

David B MacLean et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.